Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Genetic Mutation Analysis Market Size And Revenue Outlook Through 2030
The genetic mutation analysis market has seen substantial growth in its size over recent years. Its value is forecast to rise from $6.65 billion in 2025 to $7.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The expansion observed in prior periods can be linked to several factors, including limited availability of advanced sequencing technologies, increasing public awareness of genetic disorders, intensified research in oncology and inherited diseases, the widespread adoption of PCR and microarray technologies, and the early development of bioinformatics tools.
The genetic mutation analysis market is projected to expand quickly over the coming years, anticipated to reach $11.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.5%. This expansion during the projection period stems from progress in CRISPR and NGS platforms, a broadening of pharmacogenomics research, increased funding for genetic testing infrastructure, the incorporation of AI-powered data interpretation tools, and growing partnerships between research institutions and biotechnology firms. Key trends observed for this period encompass a greater uptake of next-generation sequencing and CRISPR technologies, a surge in the need for personalized medicine and targeted treatments, the broadening of genetic testing provisions within clinical diagnostics, the amalgamation of bioinformatics and data analysis platforms, and increased investigation into rare genetic disorders and pharmacogenomics.
Get A Free Sample Report With In-Depth Market Insights:
Genetic Mutation Analysis Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of genetic conditions is anticipated to drive the expansion of the genetic mutation analysis market in the coming years. These disorders are illnesses resulting from anomalies or changes in an individual’s DNA, which can be passed down or emerge spontaneously. A contributing factor to the heightened occurrence of genetic disorders is advanced parental age, as it elevates the risk of genetic mutations during reproduction, subsequently increasing the probability of these conditions in children. Genetic mutation analysis identifies alterations in genes that may cause or indicate genetic disorders, facilitating early detection, precise treatment strategies, and well-informed choices regarding reproduction or lifestyle. For example, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, showed that 11,148 cystic fibrosis patients were registered in 2022, and this figure rose to 11,318 in 2023, representing a 1.5% increase in patient registrations year-over-year. Consequently, the growing prevalence of genetic disorders is fueling the expansion of the genetic mutation analysis market.
Genetic Mutation Analysis Market Segment Analysis: What Are The Core Market Categories?
The genetic mutation analysis market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics
4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories
Subsegments:
1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems
2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools
3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services
Genetic Mutation Analysis Market Industry Trends: What’s Reshaping Demand?
Companies operating in the genetic mutation analysis market are concentrating on creating advanced solutions, such as tissue-based next-generation sequencing (NGS) tests, to improve accuracy in detecting actionable genetic changes and inform tailored treatment approaches. Tissue-based next-generation sequencing (NGS) tests serve as sophisticated diagnostic instruments that examine DNA or RNA from tissue samples to find genetic mutations, alterations, or biomarkers linked to conditions like cancer. As an illustration, Guardant Health Inc., a US-based oncology firm, introduced the Guardant360 TissueNext test in June 2024, which expanded the detection of genes in a tumor tissue sample to 498. These specific genes, or cancer biomarkers, assist oncologists in pinpointing the most effective targeted therapies or treatment strategies for individuals with advanced cancer. Furthermore, Guardant has enhanced the test’s operational processes for quicker results. The new Guardant360 TissueNext test will be eligible for coverage for Medicare fee-for-service patients suffering from advanced solid tumor cancers as a distinct offering, according to coverage provided by Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), under the existing local coverage determination.
Genetic Mutation Analysis Market Top Companies Driving Competitive Growth
Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, BGI Genomics Co. Ltd.
View The Full Genetic Mutation Analysis Market Report:
Genetic Mutation Analysis Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the genetic mutation analysis market in 2025. The regions covered in the genetic mutation analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
